| CIHR Institutes |
| ICRH Home |
| About ICRH |
| ICRH Funding |
| ICRH Publications & Resources |
| Strategic Plan |
| Annual Reports |
| Archived News |
| ICRH Calendar of Events |
| Contact ICRH |
Sponsored by:
Aventis Pharma Inc., a member of the sanofi-aventis Group
CIHR/Rx&D Research Program
The Canadian Hypertension Society
The Canadian Coalition for High Blood Pressure Prevention and Control
The mandate of the Chair will be to focus on improving the awareness, prevention and control of hypertension by interaction with federal and provincial health care agencies, health care-providers and the community at large. The Chair will interact with and enhance current Canadian programs, identify gaps in hypertension prevention and control and develop new policies, programs and clinical interventions as necessary. Implementation and outcomes research to evaluate hypertension programs are a priority.
Full Application deadline: November 1, 2005
Anticipated notification of decision: December 2005
